# Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

> **NCT00219986** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 12 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Potent HAART during acute or early HIV-1 infection

## Key facts

- **NCT ID:** NCT00219986
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 12 (—)
- **Last updated:** 2007-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219986, "Phase I/II, Open-Label Trial of Three Monoclonal Antibodies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00219986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*